Back

CMR is the only modality needed for anthracycline cardiotoxicity.

27 May 2017 (10:22 - 10:34)
Organised by:
Congress Presentation Part of: CMR in Special Patient Populations Cardiac Magnetic Resonance EACVI Premium Access EuroCMR 2017

About the speaker

Photo
Professor Charlotte Manisty

University College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Echo is the only modality needed for anthracycline cardiotoxicity.
Professor J. Plana (Philadelphia, US)
Slides
Presentation thumbnail
CMR and transplantation.
Doctor C. Miller (Manchester, GB)
Slides
Presentation thumbnail
CMR in rheumatology.
Professor N. Ntusi (Cape Town, ZA)
Slides
Presentation thumbnail
CMR of the aging heart.
Assistant Professor E. Schelbert
Slides

Access the full session

Session thumbnail
CMR in Special Patient Populations

The Event

Event poster

EuroCMR 2017

27 May 2017 10:22 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac computed tomography and magnetic resonance for precision diagnosis and monitoring for better outcome
1 September 2025
thumbnail
Congress Presentation
Cardiac troponins and anthracycline cardiotoxicity: a sub study of the PROACT trial; are all assays made equal?
21 June 2025
thumbnail
Congress Presentation
A practical approach to cardiac imaging in adults with Duchenne muscular dystrophy - echocardiography or cardiac MRI?
6 May 2021
thumbnail
Congress Presentation
Use of CMR in the assessment of cardiovascular reserve in patients treated with CAR-T therapy
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources